Liothyronine Sodium
- Product NDC
- 50090-3131
- 11-digit product format
- 500903131
- Labeler code
- 50090
- Product ID
- 50090-3131_b001b18d-9985-47dd-983d-9a6e8522c7d7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Liothyronine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA200295
- Marketing category
- ANDA
- Marketing start
- 2012-12-03
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 5 ug/1
- Pharmacologic classes
- Triiodothyronine [CS], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Liothyronine Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LIOTHYRONINE SODIUM | 5 ug/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GCA9VV7D2N |
| Rxcui | 903456 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50090-3131-0 | 2023-02-07 | C162847 | 48780-1 | f386c64a-0451-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS, USP safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS, USP. LIOTHYRONINE SODIUM TABLETS, USP, for oral use Initial U.S. Approval: 1956 |
| 50090-3131-1 | 2023-02-07 | C162847 | 48780-1 | f386c64a-0451-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS, USP safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS, USP. LIOTHYRONINE SODIUM TABLETS, USP, for oral use Initial U.S. Approval: 1956 |
| 50090-3131-0 | 2023-01-30 | C162847 | 48780-1 | f386c64a-0451-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS, USP safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS, USP. LIOTHYRONINE SODIUM TABLETS, USP, for oral use Initial U.S. Approval: 1956 |
| 50090-3131-1 | 2023-01-30 | C162847 | 48780-1 | f386c64a-0451-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use LIOTHYRONINE SODIUM TABLETS, USP safely and effectively. See full prescribing information for LIOTHYRONINE SODIUM TABLETS, USP. LIOTHYRONINE SODIUM TABLETS, USP, for oral use Initial U.S. Approval: 1956 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-3131-0 | Liothyronine Sodium | 100 in 1 BOTTLE | TABLET | 100 | | 11 |
| 50090-3131-1 | Liothyronine Sodium | 90 in 1 BOTTLE | TABLET | 90 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-3131 | LIOTHYRONINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 11 | Current NDC, Legacy NDC, 2 package rows | 20240131_db65bcd8-e9c9-4095-9975-03be1f443823.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-3131-0 | 50090313100 | 100 TABLET in 1 BOTTLE (50090-3131-0) | 100 tablet | 2017-09-05 | 0000-00-00 | No | No | Current |
| 50090-3131-1 | 50090313101 | 90 TABLET in 1 BOTTLE (50090-3131-1) | 90 tablet | 2018-03-12 | 0000-00-00 | No | No | Current |